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EGFR and IL-1 Signaling Synergistically Promote
Keratinocyte Antimicrobial Defenses in a
Differentiation-Dependent Manner
Andrew Johnston1, Johann E. Gudjonsson1, Abhishek Aphale1, Andrew M. Guzman1, Stefan W. Stoll1 and
James T. Elder1,2
Ligands of the EGF family regulate autocrine keratinocyte proliferation, and IL-1 family cytokines orchestrate
epithelial defense responses. Although members of both families are overexpressed in wound healing and
psoriasis, their roles in regulating the innate immune functions of keratinocytes remain incompletely explored.
Using sensitive assays, we found significant increases of heparin-binding EGF-like growth factor, transforming
growth factor-a, and amphiregulin mRNA and protein in lesional psoriasis compared with uninvolved or control
skin. In normal human keratinocyte (NHK) monolayers, EGFR ligands were ineffective in inducing DEFB4,
S100A7, and CCL20 mRNAs and human b-defensin (hBD)-2 peptide. Combined with IL-1a, however, EGFR
ligands provoked 250 more DEFB4 and CCL20 and a 9-fold rise in S100A7 mRNA relative to the EGFR ligand
alone. This synergy was also reflected in secreted hBD-2 protein, both from NHK and reconstituted human
epidermis. Keratinocyte differentiation was critical for these responses, as postconfluent NHK yielded mRNA
and protein levels an order of magnitude greater than subconfluent cells. Differentiation also influenced signal
transduction, with subconfluent cells using NF-kB and postconfluent cells using EGFR, MEK1/2, and p38. We
propose that EGFR ligands are important modifiers of IL-1 activity, synergizing with IL-1 to stimulate epidermal
production of hBD-2, S100A7, and CCL20, three of the most upregulated transcripts in psoriatic plaques.
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INTRODUCTION
Many members of both the interleukin (IL)-1 and the EGF
families are overexpressed in wounded skin (Marikovsky
et al., 1993; Barrientos et al., 2008) and inflammatory
dermatoses such as psoriasis (Camp et al., 1986; Elder
et al., 1989; Cook et al., 1992; Piepkorn, 1996; Stoll and
Elder, 1998; Piepkorn et al., 2003; Yoshida et al., 2008).
Epidermal keratinocytes (KCs) respond to injury by becoming
hyperproliferative, migratory, and proinflammatory in
processes regulated by cytokines and growth factors. IL-1
was the first cytokine detected in skin (Luger et al., 1982) and
is important in directing these responses. Both pro-IL-1a and
pro-IL-1b are present in normal epidermis (Kupper et al.,
1986; Feldmeyer et al., 2007). Pro-IL-1a is active and
preformed pro-IL-1a is secreted by KCs under conditions of
cell stress (Kondo et al., 1994), whereas pro-IL-1b requires
inflammasome-mediated processing for activity (Franchi
et al., 2009). Once secreted, these isoforms have similar
functions, acting in an autocrine manner and also on
local fibroblasts, vascular endothelium, and lymphocytes.
Interestingly, IL-1a-treated normal human KCs (NHKs) have
a transcriptional signature that closely resembles differences
observed in lesional versus nonlesional psoriatic skin
(Mee et al., 2007).
The family of human growth factors capable of binding to
the epidermal growth factor receptor (EGFR) is composed
of seven members: EGF, transforming growth factor (TGF)-a,
heparin-binding EGF-like growth factor (HB-EGF), amphir-
egulin (AREG), epiregulin (EREG), betacellulin (BTC), and
epigen (EPGN). Many of these have been reported to
be overexpressed in wounded skin (Marikovsky et al.,
1993; Barrientos et al., 2008) and in psoriasis (Elder et al.,
1989; Cook et al., 1992; Piepkorn, 1996; Stoll and Elder,
1998; Piepkorn et al., 2003; Yoshida et al., 2008) with the
exception of BTC which is less abundant in lesional psoriasis
skin (Piepkorn et al., 2003) and EGF which is undetectable
in skin (Rittie et al., 2007). These growth factors bind to
homo- and heterodimers formed by the four members of the
ErbB family of receptor tyrosine kinases in a hierarchical
& 2011 The Society for Investigative Dermatology www.jidonline.org 329
ORIGINAL ARTICLE
Received 9 February 2010; revised 26 July 2010; accepted 2 September 2010;
published online 21 October 2010
1Department of Dermatology, University of Michigan, Ann Arbor, Michigan,
USA and 2Ann Arbor VA Hospital, Ann Arbor, Michigan, USA
Correspondence: Andrew Johnston, Department of Dermatology, University
of Michigan, 7417 Medical Sciences Building 1, 1301 E Catherine,
Ann Arbor, Michigan 48109, USA. E-mail andjoh@med.umich.edu
Abbreviations: AMP, antimicrobial peptide; AREG, amphiregulin;
BTC, betacellulin; EPGN, epigen; EREG, epiregulin; hBD, human b-defensin;
HB-EGF, heparin-binding EGF-like growth factor; KC, keratinocyte; NHK,
normal human keratinocytes; NN, normal control skin; PN, uninvolved
psoriasis; PP, plaque psoriasis; RHE, reconstituted human epidermis;
TGF, transforming growth factor
manner (Olayioye et al., 2000). EGFR (ErbB1) is expressed
on the surface of human skin KCs, whereas ErbB2 is located
intracelluarly until KCs reach the upper suprabasal layers
(Stoll et al., 2001). Although there is likely some redundancy
within this system, each of the EGFR ligands differ in their
ability to stimulate EGFR tyrosine phosphorylation and
exhibit context-dependent functional specificity (Stoll et al.,
2010). However, their specific roles in the pathophysiology
of epidermal hyperplasia remain unclear.
Recently, there has been an increased awareness of the
role of the innate immune system in skin diseases (Yamasaki
and Gallo, 2008). Several antimicrobial peptides (AMPs) are
highly overexpressed in psoriasis, including S100A7 (Madsen
et al., 1991), S100A8/S100A9 (Kelly et al., 1989), and human
b-defensin-2 (hBD-2) (Harder et al., 1997). Moreover,
peptides such as CCL20 (MIP-3a), discovered on the basis
of their chemotactic properties, also have antimicrobial
activity (Chan et al., 2008). IL-1a and IL-1b markedly
increase the expression of AMPs by human KCs (Liu et al.,
2002) and positive interactions between the EGF and
IL-1 signaling systems have been reported in human KCs
(Lee et al., 1991; Chen et al., 1995; Wan et al., 2001).
However, the interaction of the IL-1 and EGF signaling
systems in regulating the expression of AMPs has not been
explored.
To address these issues, we assessed EGFR ligand
expression in healthy and psoriasis skin and then investigated
the potential synergism between these growth factors and
IL-1a for the induction of AMPs. We show that IL-1a
synergizes with all EGF-like growth factors for the induction
of hBD-2, CCL20, and S100A7. The response of KCs was
highly dependent on their state of differentiation and
corresponded to the sequence of stratified differentiation in
skin. These data strongly suggest that multiple EGFR and
IL-1R ligands are active in the epidermis and synergize at
multiple levels for the induction of AMP and chemokines in
the context of epidermal stress responses.
RESULTS
Multiple EGFR ligands are overexpressed in lesional
psoriasis skin
To globally analyze the overexpression of EGF-like growth
factors in lesional psoriasis skin, we prepared RNA and
protein fractions from lysates of 6mm skin biopsies and
analyzed EGFR ligand mRNA expression by quantitative
real-time reverse transcriptase PCR and protein expression
by multiplex bead array assay. Transcripts of HB-EGF were
increased 3-fold (Po0.01), TGF-a 2.3-fold (Po0.001),
AREG 3.4-fold (Po0.001) and EPGN 14-fold (Po0.01) in
plaque psoriasis (PP) compared with uninvolved psoriasis
(PN) (Figure 1a). In contrast, BTC mRNA expression was
decreased 10-fold (Po0.001) in PP skin compared with PN
skin (Figure 1a). EGFR ligand mRNA was not significantly
different in PN or healthy control (NN) skin. In support of this
we found the tissue level of HB-EGF protein was increased
3.6-fold (Po0.05), TGF-a 3.0-fold (Po0.05), and AREG
3.8-fold (Po0.05) in tissue lysates from PP versus PN skin
(Figure 1b). Consistent with transcript levels, PN and NN skin
did not have significantly different protein expression levels
of EGF-like growth factors (Figure 1b).
IL-1a and key EGFR ligands synergize for the production of
antimicrobial peptides
To understand the combined effect of elevated levels of IL-1
and EGFR ligands in the epidermis, we treated monolayer
NHK cultures with EGF, HB-EGF, TGF-a, AREG, BTC, and
EREG in combination with IL-1a. When NHKs were treated
with EGFR ligands alone, we did not detect appreciable
fold-increases in AMP mRNA (Figure 2a and b). However, in
combination with 10 ngml1 IL-1a, all the ErbB ligands
induced robust increases in CCL20 (on average 900-fold),
DEFB4 (400-fold), and S100A7 (26-fold) mRNA levels
(Figure 2a and b). Neither S100A8 nor S100A9 mRNAs
was synergistically increased (Figure 2b). The induction of
CCL20 occurred with faster kinetics compared with DEFB4
(Figure 2c). The synergy between IL-1a and the EGFR ligands
was also evident from the secretion of hBD-2 that was
increased 3.4-fold (Po0.01; Figure 2d).
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Figure 1. EGFR ligand expression in skin. Epiregulin (EREG), HB-EGF, TGF-a,
amphiregulin (AREG), and epigen (EPGN) RNA transcripts were all more
abundant in plaque psoriasis (PP, black) than symptomless psoriasis (PN, gray)
or healthy control (NN, open bars) skin, whereas betacellulin (BTC)
expression was decreased in PP skin (a). In support of this we found that
HB-EGF, TGF-a, and AREG proteins were all substantially elevated in PP
versus PN or NN skin (b). Bars represent mean ± SD, n¼ 10 donors for
mRNA, n¼4 for protein measurements. Statistical significance determined
by two-tailed t-test and indicated. *Po0.05, **Po0.01, ***Po0.001.
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Cell density and calcium concentration are critical factors
governing the responses of NHK in vitro
In human epidermis, AMP expression is typically a feature
of the suprabasal, more differentiated, KCs and not the
proliferative basal layers. This behavior is mimicked by
monolayer NHK cultures, which, at a subconfluent cell
density, showed relatively little inducible DEFB4 mRNA and
hBD-2 protein expression (Figure 3a-d). However, as the
cell density increased through confluency to 4 days
postconfluency, we observed a dramatic increase in AMP
transcription and protein secretion: S100A7 and DEFB4
mRNAs were increased 80- and 40-fold, respectively,
and hBD-2 and CCL20 secretion increased by 30- and
66-fold for cells stimulated with IL-1aþTGF-a (Figure 3e-h).
The effect of increased extracellular calcium was
only evident in subconfluent cultures, where hBD-2
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Figure 2. IL-1a and EGFR ligands synergize for the induction of CCL20 and S100A7 but not S100A8 or S100A9 expression by KCs. Postconfluent NHKs were
treated with 10ngml1 IL-1a in combination with 2 nM EGF, 2 nM HB-EGF, 4nM TGF-a, 2 or 20nM AREG, 2nM BTC, or 2nM EREG. RNA was quantified by
quantitative real-time reverse transcriptase PCR normalized to the housekeeping gene RPLP0. (a) DEFB4, CCL20, and (b) S100 family mRNA expression at 4 hours
of stimulation shows synergism between IL-1a and EGFR ligands for DEFB4, CCL20, and S100A7 but not S100A8 or S100A9 induction. (c) CCL20 (circles) and
DEFB4 (squares) have markedly different kinetics with CCL20 mRNA occurring as an early response to IL-1a (closed symbols) or IL-1a þ TGF-a (open symbols).
(d) The synergism is evident at the protein level as shown by secreted hBD-2 at 24hours of culture measured by ELISA. Open bars, EGFR ligand alone; filled bars,
IL-1aþ EGFR ligand. Mean±SD, n¼ 3. Statistical significance determined by two-tailed t-test versus control or IL-1a-treated cultures, indicated *Po0.05,
**Po0.01, ***Po0.001. BTC, betacellulin; HB-EGF, heparin-binding EGF-like growth factor; KC, keratinocyte; NHK, normal human keratinocyte.
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secretion could be doubled (Po0.01 for IL-1a stimulation;
Figure 3c).
Postconfluent KCs mainly express suprabasal keratins and have
altered IL-1 and ErbB receptor expression
To begin to examine the differences between sub- and
postconfluent NHK cultures, we surveyed cytokeratin
expression. Postconfluent NHK had keratin expression
profiles similar to epidermal suprabasal KCs, with elevated
levels of the suprabasal-associated cytokeratin (K)1 (Po0.01)
and K10 (Po0.05) and significantly decreased levels of
basal-layer-associated K5 (Po0.001) and K14 (Po0.001)
compared with their subconfluent counterparts (Figure 4a).
Next, we examined whether these cells differed in their
expression of EGF or IL-1 receptors. There was no significant
difference in EGFR (ErbB1) transcript expression by sub- or
postconfluent cells, however, both ErbB2 and ErbB3 were
expressed at significantly higher levels by postconfluent cells
(Po0.001; Figure 4c). There were no differences in receptor
transcript expression from NHK maintained in low (0.1mM)
or high (1.4mM) calcium environments (not shown). In terms
of IL-1 receptors, subconfluent NHK expressed six times
more mRNA for the IL-1 decoy receptor, IL-1RII (Po0.001;
Figure 4b) compared with postconfluent cells. In contrast,
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Figure 3. Cell density rather than extracellular calcium concentration is crucial to the responses of KCs in vitro. The effect of increased extracellular Ca2þ is
only obvious under proliferative conditions (a-d). Subconfluent, proliferating NHKs (a-d), or 4-day postconfluent NHKs (e-h) were starved of growth factors and
then treated with 10 ngml1 IL-1a and/or 4 nM TGF-a for 24 hours. Secreted hBD-2 and CCL20 were assayed by ELISA, S100A7, DEFB4, and CCL20 mRNA
quantified by quantitative real-time reverse transcriptase PCR relative to the housekeeping gene RPLP0. Filled bars¼0.1mM, open bars¼1.4mM Ca2þ indicate
mean ± SD, n¼ 3. Statistical significance (two-tailed t-test) indicated ~Po0.05, ~~Po0.01 for low versus high calcium and *Po0.05, **Po0.01,
***Po0.001 for untreated versus IL-1a and IL-1aþ TGF-a. Note differences in y axis scaling. KC, keratinocyte; NHK, normal human keratinocyte.
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there were no significant differences in IL-1RI or IL-1RAcP
expression.
Subconfluent and postconfluent KCs use different signal
transduction pathways
In an effort to identify the signal transduction pathways
involved in the synergism between IL-1R and EGFR, we used
a number of pharmacological signaling inhibitors. We found
that the IL-1a and IL-1aþTGF-a-induced DEFB4 mRNA
expression could be blocked by pretreatment with the NF-kB
inhibitor parthenolide in subconfluent (Figure 5a, Po0.05
and o0.001) but not in postconfluent NHK cultures
(Figure 5b), suggesting a switch in signaling pathways. Owing
to the low levels of secreted hBD-2 by subconfluent NHK, the
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Figure 5. Differential use of signal transduction pathways by (a) sub- and (b) postconfluent KCs in culture. NHKs were grown to the specified confluency,
starved of growth factors overnight, and then treated with one of each of the following inhibitors for 1 hour before stimulation with 10 ngml1 IL-1a (blue bars)
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or p38 (SB202190). Bars indicate mean ± SD, n¼ 3 representative of three separate experiments. Statistical significance indicated, *Po0.05, **Po0.01,
***Po0.001, two-tailed t-test versus vehicle control. (c) Sub- and postconfluent NHKs were stimulated with 10 ngml1 IL-1a and/or 4 nM TGF-a for 30minutes
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KC, keratinocyte; NHK, normal human keratinocyte.
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effect of parthenolide pretreatment was not apparent at the
protein level (not shown). Further, inhibition of Src family
kinase activity with PD173952 blocked IL-1a- and
IL-1aþTGF-a-induced DEFB4 mRNA expression in both
subconfluent and postconfluent NHK (Po0.001, Figure 5a
and b). In contrast, DEFB4 expression in postconfluent cells
was much more sensitive to inhibition of ErbB tyrosine
kinases (PD158780, Po0.001), MEK1/2 (U0126, Po0.001),
and p38MAPK (SB202190, Po0.001) than in subconfluent
NHK (Figure 5a and b). We also analyzed the expression of
10 key phosphoproteins involved in KC signal transduction.
Figure 5c shows these data expressed both as absolute values
and as the fold change of phosphoprotein expression
of postconfluent over subconfluent cells. It is evident that
IL-1a-stimulated postconfluent cells increase their usage of
ERK1/2 (4.6-fold, P¼0.002), MEK1 (3.5-fold, Po0.001), JNK
(5-fold, P¼0.01), and p38 MAPK (5-fold, Po0.05) compared
with subconfluent cultures.
To further explore the mechanism by which IL-1a and
EGFR ligands synergize, we examined IL-1a, IL-1b, IL-1ra,
and IL-1R (Supplementary Figure S1 online) mRNA
expression by EGFR-treated KCs. EGF, HB-EGF, and TGF-a
significantly increased IL-1a, IL-1b, and IL-1RA and also
increased the expression of IL-1R2. Conversely, IL-1a
significantly increased AREG (1.8-fold), EGF (2.8-fold),
Ereg (1.9-fold), HB-EGF (2.5-fold), and TGF-a (3-fold) mRNA
at 24 hours (Supplementary Figure S2a-h online) but failed to
alter ErbB receptor expression (Supplementary Figure S2g
online). Further, sequential treatment experiments revealed
that both IL-1a and TGF-a must be present simultaneously
to induce hBD-2 secretion synergistically (Supplementary
Figure S3 online).
IL-1a and EGFR synergistically induce AMP expression in
reconstituted epidermal cultures
Synergism between IL-1a and EGFR ligands was also
apparent in reconstituted human epidermal (RHE) cultures
(Figure 6). TGF-a alone induced a hyperplastic response, but
no hBD-2 (Figure 6b). hBD-2 was clearly induced in the
suprabasal layers of the RHE by IL-1a, in a strikingly
differentiation-related expression pattern (Figure 6c). Indica-
tive of secretion, large amounts of hBD-2 were found in the
underlying culture medium of IL-1a-treated cultures (Figure
6e). In combination with TGF-a, IL-1a induced a more diffuse
pattern of hBD-2 expression throughout the basal and spinous
layers (Figure 6d) which was accompanied by a 5-fold
increase in hBD-2 secretion (24 hours, P¼0.003) when IL-1a
was combined with TGF-a (Figure 6e). The IL-1aþTGF-a-
treated cultures showed a more compressed morphology
of their viable cell layers and loss of the granular layer
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Figure 6. The synergistic effects of IL-1a and TGF-a are evident on reconstituted human epidermal cultures. Cultures were treated for 48 hours with 10 ngml1
IL-1a, 4 nM TGF-a, or both, and then processed and immunohistochemically stained for hBD-2 (a-d), or loricrin and involucrin (f). Untreated cultures show no
hBD-2 expression (a); this is true also of TGF-a treatment that resulted in a thickened epidermal layer (b). IL-1a treatment induced a strong vectorial hBD-2
expression (c), whereas treatment with both IL-1aþTGF-a resulted in altered tissue morphology with enhanced hBD-2 expression (d). The altered epidermal
structure was accompanied by decreased loricrin and more extensive involucrin expression in IL-1aþ TGF-a-treated cultures (f). To confirm the secretion
of hBD-2, culture medium was sampled at 24 hours (open bars) and 48 hours (filled bars) and hBD-2 was assayed by ELISA (e). Bars indicate mean±SD,
n¼ 5. Statistical significance determined by two-tailed t-test IL-1a versus IL-1aþTGF-a, **Po0.01. Scale bar¼100 mm.
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(Figure 6d) that was accompanied by loss of loricrin
expression and a more widespread expression of involucrin
in the cultures (Figure 6f).
DISCUSSION
In addition to increased proliferation, KC differentiation is
markedly altered in psoriasis (Ghadially et al., 1996), and the
processes occurring in wound healing and psoriatic epider-
mis have been likened to a distinctive pattern of epidermal
differentiation termed regenerative hyperplasia (Mansbridge
et al., 1984). EGFR ligand expression is increased in
wounded skin, and signaling through EGFR has been strongly
implicated in the re-epithelialization phase of skin (Reper-
tinger et al., 2004) and corneal wound healing (Nakamura
et al., 2001). Despite considerable evidence for increased
expression of EGFR ligands in psoriasis lesions, reversion
of psoriasis-associated phenotypes in response to inhibition
of EGFR in skin organ culture (Varani et al., 1998), and in
response to anti-amphiregulin antibodies in xenografted
lesional psoriatic skin (Bhagavathula et al., 2005), the precise
role of EGFR signaling in psoriasis remains to be fully
elucidated.
We show significant overexpression of TGF-a, HB-EGF,
AREG, EREG, and EPGN mRNAs, and TGF-a, HB-EGF, and
AREG proteins in psoriasis, in the most globally comparative
assessment of these parameters to date. We then show that
multiple EGFR ligands synergize with IL-1a to induce AMP
expression, both in NHK and in RHE, resulting in robustly
increased CCL20, DEFB4, and S100A7 mRNA, and secreted
hBD-2 peptide from monolayer NHK and stratified RHE
cultures. Such synergy would be beneficial for the control of
AMP expression at a site of wounding, and likely contributes
to the hyperplasia, AMP expression, and immunocyte
infiltrate in psoriasis. However, using purified IL-1 and
TGF-a to stimulate three-dimensional RHE cultures, we were
unable to recapitulate the pronounced and distinctive
epidermal hyperplasia characteristic of psoriasis (Figure 6d),
suggesting that other mechanisms are likely to be at play
in vivo.
A mixed immunocytic infiltrate is characteristic of both
wound healing and psoriasis. Recently, we have found that
stimulated blood monocytes express IL-1, EREG, and HB-EGF
(A Johnston, unpublished observations), and could therefore
be a source of both IL-1 and EGFR ligands. As EGFR and
IL-1R family members also synergize to induce expression of
chemokines such as CCL20 by KC this interaction may
promote and/or sustain the inflammatory response by driving
further leukocyte infiltration.
AMP expression is restricted to the spinous and granular
layers of the skin (Ong et al., 2002; de Jongh et al., 2005), and
cytokine-induced expression of hBD-2 by NHK is markedly
increased after in vitro differentiation (Harder et al., 2004).
Consistent with this, we found that postconfluent NHKs,
which share the keratin expression profile of suprabasal
KC (Figure 4a; De Potter et al., 2001), were much more
responsive to IL-1a stimulation than their subconfluent
counterparts, expressing on average 10 times more S100A7
and DEFB4 mRNAs and hBD-2 and CCL20 proteins than
subconfluent cells (Figure 3). To begin to elucidate the source
of this difference, we measured EGFR and IL-1R transcript
expression. We found that although IL-1RI and IL-1RAcP are
not differentially expressed, the decoy receptor, IL-1RII, is
6-fold more abundant in subconfluent cultures (Po0.001,
Figure 4b). This receptor, like IL-1RI, binds IL-1a and -1b and
IL-1RAcP but cannot initiate signal transduction due to the
lack of a cytoplasmic TIR domain. Thus increased expression
of this receptor leads to decreased responsiveness to IL-1a/b,
which is supported by the increased use of MEK1, p38, p65,
and JNK in postconfluent NHK (Figure 5c). The loss of IL-1RII
expression as KC mature in normal epidermis would confer a
greater degree of sensitivity to IL-1 signals and appropriate
expression of AMPs in the higher strata of the epidermis.
EGFR (ErbB1) was not significantly different between sub-
and postconfluent cells, and as anticipated, ErbB4 was
undetectable (De Potter et al., 2001; Stoll et al., 2001).
However, ErbB2 and ErbB3 transcripts were both significantly
elevated in postconfluent cultures, in accordance with the
increased expression of ErbB2 by the more differentiated KC
in the suprabasal layers of the skin (De Potter et al., 2001;
Stoll et al., 2001). If these results were indicative of protein
expression in the cell membrane, then ErbB heterodimer
formation could contribute to the increased responses to
IL-1a and EGFR ligand stimulation observe here, as ErbB
hetereodimers have been reported to show increased
ligand affinity and higher signal potency (Pinkas-Kramarski
et al., 1996).
The increased sensitivity of postconfluent NHK to inhibi-
tion of MEK1/2 and p38MAPK (Figure 5a and b) was also
reflected in their enhanced usage (Figure 5c). We observed a
10-fold increase in HSP27 phosphorylation in unstimulated
postconfluent compared with subconfluent NHK, which is
consistent with increased HSP27 expression during epider-
mal cell differentiation (Gandour-Edwards et al., 1994; Jonak
et al., 2002) and that oligomers of phospho-HSP27 are
required for the folding of transglutaminase, loricrin, and
filaggrin for the formation of the cornified cell envelope
(Jonak et al., 2002). The most consistently and dramatically
downregulated phosphoprotein was the transcription factor
CREB, which was expressed in postconfluent cells at only half
the levels observed for subconfluent NHK (Figure 5c),
consistent with its role in repressing loricrin, the major
protein of the cornified envelope (Jang and Steinert, 2002).
Although the signaling profiles of sub- and postconfluent cells
presented in Figure 5 do not fully elucidate the mechanism of
synergy between EGFR and IL-1 signaling, they do mirror the
functional differences the basal and suprabasal KCs.
In an effort to better understand the mechanism of IL-1-
EGFR ligand synergy, we assessed the effect of one family of
ligands on expression of ligands and receptors for the other.
In accord with earlier findings for TGF-a (Lee et al., 1991),
EGF, HB-EGF, and TGF-a all induced IL-1a and IL-1b mRNA
in NHK (Supplementary Figure S1 online). Conversely, IL-1a
induced EGFR ligands (Supplementary Figure S2 online),
including secreted AREG and TGF-a proteins. We also
observed induction of IL-1RA and IL-1RII (Supplementary
Figure S1c and e online) transcripts by EGF, HB-EGF, and
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TGF-a, which may to some extent balance the induced IL-1a
and IL-1b.
Finally, with RHE cultures when IL-1a and TGF-a were
combined we measured a 5-fold increase in secreted hBD-2
and observed the loss of the granular layer (Figure 6d) and
loricrin expression (Figure 6f), which occurs in psoriasis
lesions, suggesting that the combined effects of IL-1 and
EGFR ligands can contribute to the altered maturation of KC
evident in psoriasis skin.
On the basis of these studies, we propose that EGFR
ligands are important modifiers of the activity of IL-1a, and
these data are consistent with the cooperation of the IL-1 and
EGFR systems in promoting efficient wound healing with
EGFR ligands enhancing KC motility and the synergistic
induction of AMPs to suppress opportunistic microbial
growth both by direct antimicrobial activity and by recruit-
ment of immunocytes to the skin. However, the experimental
systems used here do not fully recapitulate the complex,
multicellular environment of human skin. Future studies
should explore the responses studied in this report in more
complex experimental models of the skin.
MATERIALS AND METHODS
Study population
In all, 10 individuals with chronic PP and 10 normal controls were
enrolled (mean age 26.9 years, range 18–75 years). Entry criteria
were the manifestation of one or more well-demarcated, scaly,
erythematous psoriatic plaques that were not limited to the scalp and
no systemic antipsoriatic treatments for 2 weeks before biopsy.
Biopsies sites varied between patients depending on site of active
plaques whereas biopsies of uninvolved and control skin were from
the buttocks. Informed written consent was obtained from all
subjects, under protocols approved by the institutional review board
of the University of Michigan. This study was conducted in
compliance with good clinical practice and according to the
Declaration of Helsinki Principles.
Cell cultures
Monolayer NHK cultures were established as described (Elder et al.,
1991) and used in the second or third passage. Cultures were grown
to 40 or 80% confluence, or maintained to 4 days postconfluency.
Cultures were starved of growth factors in unsupplemented M154
medium (Invitrogen/Cascade Biologics, Portland, OR) for 24 hours
before use. Experiments were carried out under low-calcium
(0.1mM) and high-calcium (1.4mM) conditions. Cultures were
stimulated with recombinant human cytokines and growth factors
from R&D Systems (Minneapolis, MN): 0.56 nM (10 ngml1) IL-1a,
2 nM EGF, 2 nM HB-EGF, 4 nM TGF-a, 2 or 20 nM AREG, 2 nM BTC,
2 nM EREG or combinations thereof. These EGFR ligand concentra-
tions were selected on the basis of their ability to equivalently
stimulate EGFR tyrosine phosphorylation (Stoll et al., 2010).
Where used, cultures were incubated with inhibitors 1 hour
before cytokine addition. Reagents included inhibitors of EGFR
tyrosine kinase (PD158780, 1mM; EMD Chemicals, San Diego, CA),
NF-kB (parthenolide, 10 mM; Sigma), MEK1/2(U0126, 10 mM; EMD),
phosphoinositol (PI)-3-kinase (LY294002, 1mM; EMD), p38MAPK
(SB202190, 5 mM), Src family kinases (PD173952, 1mM, kindly
provided by Dr Alan Kraker and Dr Wilbur Leopold, Pfizer Global
Research and Development, Ann Arbor, MI), JNK (SP600125, 5 mM;
AG Scientific, San Diego, CA), and STAT3 (JSI-124/cucurbatacin,
10 mM; EMD) and matrix metalloproteinases (GM6001, 40 mM; EMD).
Reconstituted human epidermal cultures were obtained from
MatTek (Ashland, MA, EPI-200). After overnight equilibration,
medium was refreshed and supplemented with recombinant human
IL-1a (0.56 nM, 10 ngml1) or TGF-a (4 nM), or both. Medium was
sampled at 24 and 48 hours. Discs (4mm) were punched from RHE
cultures and were formalin fixed, paraffin embedded, sectioned at
5mm and stained for hBD-2 expression (goat polyclonal; Peprotech,
Rocky Hill, NJ), loricrin (rabbit polyclonal; Covance, Berkeley, CA),
or involucrin (clone SY5; Novocastra/Leica, Bannockburn, IL)
and visualized with 3,30-diaminobenzidine (BD Pharmingen,
San Diego, CA).
Tissue processing
Skin biopsies (6mm) were snap frozen, pulverized, and either
dissolved in complete RLT buffer (Qiagen, Valencia, CA) for RNA
extraction or complete RIPA buffer for protein quantitation. Tissue
lysates for protein quantitation were normalized to 1mgml1 total
protein before analysis. Similarly, NHKs were dissolved into 300ml
complete RLT buffer for RNA extraction.
Real-time quantitative reverse transcription PCR
RNA was isolated (RNeasy Mini kit; Qiagen), reverse transcribed
(High Capacity cDNA Transcription kit; Applied Biosystems, Foster
City, CA) and transcripts were quantified using a 7900HT Fast Real-
Time PCR system (Applied Biosystems). TaqMan primer sets were
purchased from Applied Biosystems (Supplementary Table 1 online).
All values were normalized to the expression of the housekeeping
gene ribosomal protein, large, P0 (RPLP0) (Minner and Poumay,
2009).
ELISA and Multiplexed bead assays
Conditioned culture medium was analyzed by ELISA for CCL20
(R&D Systems) and hBD-2 (Supplementary Materials and Methods
online). Phosphoproteins in NHK lysates and EGFR ligands
in medium were quantified by multiplexed assays (Supplementary
Materials and Methods online).
Statistics
Data sets were tested for normality using the Kolmogorov–Smirnov
test, and statistical significance was determined by Student’s t-test or
Mann–Whitney rank-sum tests where appropriate using SigmaPlot
v10 (Systat, Erkrath, Germany).
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